Combination Therapy for Postmenopausal Osteoporosis

被引：0

作者：

Jones, Heather Tagliarino ^{[1
]}

Howard, Ellen ^{[2
]}

机构：

[1] Swedish Med Ctr, Seattle, WA USA

[2] Univ Washington, Hlth Sci Lib, Seattle, WA 98195 USA

来源：

AMERICAN FAMILY PHYSICIAN | 2010年 / 81卷 / 04期

关键词：

PARATHYROID-HORMONE; ALENDRONATE; RALOXIFENE; WOMEN;

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：439 / 440

页数：2

共 10 条

[1]

[Anonymous], 2004, Bone Health and Osteoporosis: A report of the Surgeon General

[2]

[Anonymous], ENDOCR PRACT

[3] The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis [J].

Black, DM ;

Greenspan, SL ;

Ensrud, KE ;

Palermo, L ;

McGowan, JA ;

Lang, TF ;

Garnero, P ;

Bouxsein, ML ;

Bilezikian, JP ;

Rosen, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (13) :1207-1215

[4] Postmenopausal osteoporosis. What have we learned since the introduction of bisphosphonates? [J].

Chaiamnuay, Sumapa ;

Saag, Kenneth G. .

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2006, 7 (1-2) :101-112

[5] Combination treatment of osteoporosis: A clinical review [J].

Crandall, C .

JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2002, 11 (03) :211-224

[6] Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: Results from a 6-month double-blind placebo-controlled trial [J].

Deal, C ;

Omizo, M ;

Schwartz, EN ;

Eriksen, EF ;

Cantor, P ;

Wang, JY ;

Glass, EV ;

Myers, SL ;

Krege, JH .

JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (11) :1905-1911

[7]

Hodgson Stephen F, 2003, Endocr Pract, V9, P544

[8] Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis [J].

Johnell, O ;

Scheele, WH ;

Lu, YL ;

Reginster, JY ;

Need, AG ;

Seeman, E .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) :985-992

[9] Diagnosis, screening, prevention, and treatment of osteoporosis [J].

Mauck, KF ;

Clarke, BL .

MAYO CLINIC PROCEEDINGS, 2006, 81 (05) :662-672

[10] Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate [J].

Rittmaster, RS ;

Bolognese, M ;

Ettinger, MP ;

Hanley, DA ;

Hodsman, AB ;

Kendler, DL ;

Rosen, CJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (06) :2129-2134

← 1 →